View Post

UT Southwestern Researchers find evidence a cancer drug may be extended to many more patients

In In The News by Barbara Jacoby

Source: UT Southwestern Medical Center From: PR Newswire A new molecular mechanism discovered by UT Southwestern researchers indicates that drugs currently used to treat less than 10 percent of breast cancer patients could have broader effectiveness in treating all cancers where the drugs are used, including ovarian and prostate cancers. The new study also revealed a potential biomarker indicating when …

View Post

AI for Breast Cancer Diagnosis: The First FDA Cleared System Is Here

In In The News by Barbara Jacoby

By: Mariam Haider From: parentology.com From apps that scan for sun damage to devices that restore eyesight, Artificial Intelligence (AI) is changing how we approach healthcare. The latest in this ever-growing list: AI for breast cancer diagnosis. QuantX, created by Paragon Biosciences and Qlarity Imaging, is an AI-based breast cancer diagnosis system. It is the first ever cleared by the …

View Post

Unlocking therapies for hard-to-treat lung cancers

In In The News by Barbara Jacoby

Source: Salk Institute for Biological Studies From: prnewswire.com Salk scientists find that diabetes drug candidates may work against types of non-small-cell lung cancers Around 85 percent of lung cancers are classified as non-small-cell lung cancers, or NSCLCs. Some patients with these cancers can be treated with targeted genetic therapies, and some benefit from immunotherapies—but the vast majority of NSCLC patients …

View Post

The FDA Requests Allergan Voluntarily Recall Natrelle BIOCELL Textured Breast Implants and Tissue Expanders from the Market to Protect Patients

In In The News by Barbara Jacoby

From: fda.gov To protect individuals from the increased risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), associated with Allergan BIOCELL textured breast implants, the Food and Drug Administration (FDA) requested that Allergan recall its BIOCELL textured breast implants and tissue expanders. Allergan agreed and is removing these products from the global market. The FDA requested that Allergan recall all …

View Post

Zhang group identifies gene that may make triple-negative breast cancer cells vulnerable to existing drug

In In The News by Barbara Jacoby

Source: University of Notre Dame From: newswise.com Certain therapies that have proven effective in treating some types of breast cancers are ineffective for women diagnosed with triple-negative breast cancer (TNBC). In fact, there is limited targeted drug therapy for this type of breast cancer — the most aggressive type, diagnosed in about 20 percent of breast cancer patients. But a …

View Post

Savvy Cooperative Opportunity: Share Your Expertise as an Acute Myeloid Leukemia (AML) patient

In In The News by Barbara Jacoby

Click on the link below to see whether you qualify: Interview: Share your thoughts on living with Acute Myeloid Leukemia (AML) (Anywhere) – $125 Description: We are working on a new project and we are hoping to speak with Acute Myeloid Leukemia (AML) patients and hear about your experience living with the condition and thoughts about your current treatment regimen. …

View Post

Delay from breast cancer diagnosis to chemotherapy after an operation may shorten survival

In In The News by Barbara Jacoby

By: American College of Surgeons From: medicalxpress.com Women with breast cancer should start postoperative chemotherapy, when recommended, ideally within four months of their cancer diagnosis because new study findings show that waiting longer is associated with poorer overall survival. The study, which used nationwide data, is published as an “online first article” on the Annals of Surgical Oncology website in …

View Post

Susan G. Komen foundation expands Palm Beach County program to help low-income women navigate breast cancer

In In The News by Barbara Jacoby

By: Catie Wegman From: sun-sentinel.com When Sophia Rose felt a lump in her breast about two months ago, she didn’t know what to do. The uninsured, Lake Worth Beach resident took to Google to find answers. She found the number for Susan G. Komen Florida and called immediately, terrified of what her future held. A “navigator” met with Rose, helped …

View Post

Breast Cancer Drug Available on CDF

In In The News by Barbara Jacoby

A potentially life-extending drug combination for some people with advanced breast cancer will be made available on England’s Cancer Drugs Fund (CDF) following a recommendation by the National Institute for Health and Care Excellence (NICE). The draft guidance recommended ribociclib (Kisqali, Novartis) with fulvestrant (Faslodex, AstraZenica) as an option for people with hormone receptor-positive, human epidermal growth factor receptor 2 …

View Post

Medicare to Cover CAR-T Therapies

In In The News by Barbara Jacoby

From: genomeweb.com August 8, 2019 – The Centers for Medicare & Medicaid Services announced yesterday that it would be covering approved CAR-T therapies for Medicare patients, the Associated Press reports. The US Food and Drug Administration approved Novartis’ CAR-T therapy Kymriah about two years ago to treat a form of acute lymphoblastic leukemia and shortly thereafter approved Kite Pharmaceuticals’ Yescarta, …